Nichols R L, Smith J W, Fossedal E N, Condon R E
Rev Infect Dis. 1979 Mar-Apr;1(2):302-12. doi: 10.1093/clinids/1.2.302.
An experimental model of intraabdominal sepsis closely approximating the disease in humans was used to evaluate the efficacy of clindamycin, tobramycin, cephalothin, and cefamandole, alone and in combination, in reducing both early mortality due to peritonitis and the subsequent development of abscesses. Sepsis was induced in rats by intraperitoneal placement of gelation capsules containing various amounts of human stool inoculum. Ninety percent of the untreated animals given a high inoculum died of peritonitis within 24 hr, and the survivors showed significant intraabdominal abscesses at the time of sacrifice. Animals treated with clindamycin-tobramycin, cephalothin-tobramycin, cefamandole-tobramycin, or cefamandole alone in the high-inoculum group showed a significant decrease in early mortality. Only animals treated with clindamycin-tobramycin, however, had a significantly increased cure rate (survival with no abscess present at time of sacrifice). In low-inoculum groups, several antibiotics alone or in combination significantly decreased mortality and increased cure rates. The selective use of antibiotics is critical in the treatment of severe forms of intraabdominal sepsis.
一种与人类疾病极为相似的腹腔内脓毒症实验模型被用于评估克林霉素、妥布霉素、头孢噻吩和头孢孟多单独及联合使用时,在降低腹膜炎所致早期死亡率以及随后脓肿形成方面的疗效。通过向大鼠腹腔内植入含有不同量人类粪便接种物的凝胶胶囊来诱发脓毒症。给予高接种量的未治疗动物中,90%在24小时内死于腹膜炎,存活的动物在处死时显示出明显的腹腔内脓肿。高接种量组中,接受克林霉素-妥布霉素、头孢噻吩-妥布霉素、头孢孟多-妥布霉素或单独使用头孢孟多治疗的动物早期死亡率显著降低。然而,只有接受克林霉素-妥布霉素治疗的动物治愈率显著提高(处死时存活且无脓肿)。在低接种量组中,几种抗生素单独或联合使用均显著降低了死亡率并提高了治愈率。在严重形式的腹腔内脓毒症治疗中,抗生素的选择性使用至关重要。